Re-treatment with interferon alfa of patients with chronic hepatitis C

Hepatology

Volumn 27, Issue 4, 1998, Pages 1144-1148

  Chow, Wan Cheng ^a   Boyer, Nathalie ^a   Pouteau, Michele ^a   Castelnau, Corinne ^a   Martinot Peignoux, Michele ^a   Martins Amado, Veronique ^a   Degos, Francoise ^a   Maghinici, Crina ^b   Sinegre, Martine ^b   Benhamou, Jean Pierre ^a   Degott, Claude ^b   Erlinger, Serge ^a   Marcellin, Patrick ^a,b  

^a INSERM   (France)

^b BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ALPHAN1 INTERFERON; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; VIRUS RNA;

ADULT; ARTICLE; DRUG MEGADOSE; DRUG RESPONSE; FATIGUE; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; THROMBOCYTOPENIA; TREATMENT FAILURE;

ADULT; ANTIVIRAL AGENTS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; INTERFERON ALFA-2B; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RNA, VIRAL;

EID: 17344367586     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270432     Document Type: Article

References (20)

1. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP, Carey W, et al. Treatment of chronic hepatitis C with recombinant interferon alfa: a multicenter randomised, controlled trial. N Engl J Med 1989;321:1501-1505.
2. Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, Goodman Z, et al. Recombinant interferon alfa therapy for chronic hepatitis C: a randomised doubled-blind, placebo-controlled trial. N Engl J Med 1989;321:1506-1510.
3. Marcellin P, Boyer N, Giostra E, Degott C, Courouce AM, Degos F, Coppere H, et al. Recombinant human alpha-interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomised controlled trial from France. HEPATOLOGY 1991;13:393-397.
4. Causse X, Godinot H, Chevallier M, Chossegros P, Zoulim F, Ouzan D, Heyraud JP, et al. Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis. Gastroenterology 1991:101:497-502.
5. Saracco G, Rosina F, Abate ML, Chaindussi L, Gallo V, Cerutti E, Di Napoli A. Long term follow-up of patients with chronic hepatitis C treated with different dose of interferon-alpha 2b. HEPATOLOGY 1993;18:1300-1305.
6. Hoofnagle JH, Di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997;226:347-356.
7. Toyoda H, Nakano S, Takeda I, Kumada T, Sugiyama K, Osada T, Kiriyama S, et al. Retreatment of chronic hepatitis C with interferon. Am J Gastroenterol 1994;89:1453-1457.
8. Gerken G, Teuber G, Goergen B, Meyerzum Buschenfelde KH. Interferon-alpha retreatment in chronic hepatitis C. J Hepatol 1995;22:118-121.
9. Kakumu S, Yoshioka K. Retreatment with interferon in patients with chronic hepatitis C [Letter]. J Hepatol 1994;21:483.
10. Marriott E, Quiroga JA, Carreno Y. Retreatment of chronic hepatitis C with interferon-alpha. J Infect Dis 1992;166:1200-1001.
11. Camps J, Garcia N, Riezu-Boj JI, Civeira MP, Prieto J. Ribavirin in the treatment of chronic hepatitis C unresponsive to alfa interferon. J Hepatol 1993;19:408-412.
12. Koskinas J, Tibbs C, Saleh MG, Pereira LMMB, McFarlane IG, Williams R. Effects of ribavirin on intrahepatic and extrahepatic expression of hepatitis C virus in interferon nonresponsive patients. J Med Virol 1995;45:29-34.
13. Brillanti S, Garson J, Foli M, Whitby K, Deaville R, Masci C, Miglioli M, et al. A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C. Gastroenterology 1994;107:812-817.
14. Schvarcz R, Yun ZB, Sonnerborg A, Weiland O. Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone. J Med Virol 1995;46:43-47.
15. Kugelmas M, Lieberman BY, Carey WD. Deironisation in chronic hepatitis C patients previously non-responsive to interferon improves transaminases but not viral activity [Abstract]. Gastroenterology 1995;108:A1004.
16. Bacon BR, Rebholz AE, Fried M, Di Bisceglie AM. Beneficial effects of iron reduction therapy in patients with chronic hepatitis C who failed to respond to interferon [Abstract]. HEPATOLOGY 1993;18:150A.
17. Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, Degott C, et al. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. HEPATOLOGY 1995;22:1050-1056.
18. Marcellin P, Boyer N, Pouteau M, Benhamou JP, Erlinger S. Retreatment with interferon-alpha of chronic hepatitis C. Lancet 1994;344:690-691.
19. Alberti A, Chemello L, Noventa F, Cavalletto L, De Salvo G. Therapy of hepatitis C: re-treatment with alpha interferon. HEPATOLOGY 1997;26(Suppl. 1):137S-142S.
20. Keeffe EB, Holllinger FB, and the Consensus Interferon Study Group. Therapy of hepatitis C: consensus interferon trials. HEPATOLOGY 1997;16(Suppl. 1):101S-107S.